查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1908485

脑机介面市场规模、份额和趋势分析报告：按产品、应用、最终用途和细分市场预测（2026-2033 年）

Brain Computer Interface Market Size, Share & Trends Analysis Report By Product, Application, End Use And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

脑机介面市场概览

据估计，到 2025 年，全球脑机介面 (BCI) 市场总潜在市场规模 (TAM) 将达到 1,682.7 亿美元，从 2026 年到 2033 年，复合年增长率 (CAGR) 为 1.52%。

研究表明，脑机介面 (BCI) 能为肌萎缩侧索硬化症 (ALS)、脊髓损伤和中风等疾病患者恢復运动和沟通能力提供更大的信心。

同时，非脑机介面（non-BCI）的可用市场规模预计在2025年达到3.9759亿美元，并预计在2026年至2033年间以8.73%的复合年增长率增长。主要市场驱动因素包括需要义肢假体的疾病增加、全球老化人口的不断增长，以及瘫痪患者能够进行沟通和行动的技术进步。此外，非脑机介面在家庭控制系统、虚拟游戏、军事通讯等领域的日益普及，也提升了其市场适用性并推动了市场成长。

脑机介面（BCI）技术主要应用于医学研究领域，帮助身心障碍者控制义肢并恢復沟通能力。这些系统使用佩戴在头皮上或植入大脑的电极来收集和解读神经讯号，并将其转换为外部装置的指令。近年来，BCI技术的进步使其更加普及、经济实惠且用途广泛。市面上已有Muse和NeuroSky等消费级BCI设备。这些头戴式装置采用无线干电极，无需导电凝胶，因此配戴舒适，即使长时间使用也不会感到不适。因此，此类产品的市场供应正在推动市场成长。

神经退化性疾病的日益增加是推动脑机介面（BCI）市场成长的关键因素。阿兹海默症、帕金森氏症、肌萎缩侧索硬化症（ALS）和多发性硬化症（MS）等神经退化性疾病的特征是神经细胞进行进行性退化，导致大脑和神经系统受影响区域的功能逐渐丧失。

根据世界卫生组织的报告，到2030年，全球约有8,200万人将受到失智症的影响，预计到2050年这一数字将达到1.52亿，这表明未来几年对脑机介面（BCI）的潜在需求庞大。这些疾病会严重影响患者的运动功能、沟通能力和整体生活品质。随着世界人口老化的加剧，这些疾病的发病率预计将会上升，因此迫切需要创新解决方案来帮助控制症状、恢復丧失的功能并提高患者的生活品质。

目录

第一章调查方法和范围

第二章执行摘要

第三章 脑机介面市场变数、趋势与范围

  • 市场动态
  • 脑机介面市场分析工具
    • 产业分析：波特五力模型
    • PESTEL 分析
    • 脑机介面技术的临床测试流程
    • 用例研究

第四章：脑机介面（BCI）按应用分類的总潜在市场规模（TAM）、估算与趋势分析

  • 按应用领域分類的市场份额（2025 年和 2033 年）
  • 全球脑机介面市场：按应用领域分類的展望
  • 肌萎缩侧索硬化症（ALS）
  • 中风
  • 脊髓损伤
  • 多发性硬化症患者
  • 脑性麻痹
  • 截肢
  • 癫痫
  • 忧郁症
  • 帕金森氏症

第五章 脑机介面市场：按应用分類的估算与趋势分析

  • 按应用领域分類的市场份额（2025 年和 2033 年）
  • 全球脑机介面市场：按应用领域分類的展望
  • 医疗保健
    • 恢復受损功能
    • 脑功能修復
  • 智慧家庭控制
  • 通讯与控制
  • 娱乐游戏

第六章：脑机介面市场：最终用途、预测与趋势分析

  • 按最终用途分類的市场份额（2025 年和 2033 年）
  • 全球脑机介面市场：依最终用途分類的展望
  • 医疗保健
  • 教育与研究
  • 其他的

第七章 脑机介面市场依地区、估算及趋势分析及类型划分

  • 区域市场占有率分析（2025 年和 2033 年）
  • 区域市场概览
  • 全球区域市场概览
  • 市场规模及预测趋势分析，2021-2033年
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 主要企业市占率和地位分析（2025 年）
  • 公司简介
    • Medtronic
    • G.Tec medical engineering GmbH
    • Natus Medical Incorporated
    • Compumedics Neuroscan
    • Brain Products GmbH
    • Integra LifeSciences Corporation
    • Advanced Brain Monitoring, Inc.
    • EMOTIV
    • NeuroSky
    • ANT Neuro
    • NIRx Medical Technologies, LLC
    • Ripple Neuro.
    • Neuroelectrics
    • OpenBCI
    • COGNIONICS, INC.（CGX）
    • Blackrock Neurotech
    • Synchron
    • Neurable
Product Code: 978-1-68038-459-8

Brain Computer Interface Market Summary

The global brain computer interface (BCI) market, considering invasive BCIs, the total addressable market (TAM) was estimated at USD 168.27 billion in 2025 and is expected to grow at a CAGR of 1.52% from 2026 to 2033. Several research studies indicate that invasive BCIs offer a higher level of assurance in restoring motor function and communication capabilities in patients with conditions such as Amyotrophic Lateral Sclerosis (ALS), spinal cord injuries, and stroke.

In contrast, considering non-invasive BCIs, the serviceable obtainable market (SOM) was estimated at USD 397.59 million in 2025 and is projected to grow at a CAGR of 8.73% from 2026 to 2033. Key market drivers include the increasing prevalence of conditions requiring neuroprosthetic devices, the rising global geriatric population, and technological advancements that facilitate communication and movement in paralytic patients. Additionally, the expanding use of non-invasive BCIs in home control systems, virtual gaming, and military communication further enhances market applicability, thereby supporting market growth.

BCI technology is primarily utilized in medical and research settings to assist individuals with disabilities in controlling prosthetic limbs or restoring their communication ability. These systems employ electrodes placed on the scalp or implanted in the brain to capture and interpret neural signals, which are then converted into commands for external devices. Recently, advancements in BCI technology have made it more accessible, affordable, and versatile. Consumer-grade BCI devices, such as the Muse and NeuroSky headsets, are available in the market. These headsets utilize wireless dry electrodes that eliminate the need for conductive gel, making them comfortable for users to wear for extended periods. Thus, the availability of such products in the market boosts the market growth.

The increasing prevalence of neurodegenerative disorders is a significant driver of growth in the BCI market. Neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), and Multiple Sclerosis (MS), are characterized by the progressive degeneration of neurons, leading to a gradual loss of function in the affected areas of the brain and nervous system.

According to the WHO report, around 82 million people will be affected by dementia by 2030 and this number will reach 152 million by 2050. This shows the potential demand for BCI in the coming years. These conditions can severely impact an individual's motor functions, communication abilities, and overall quality of life. As the global population ages, the incidence of these disorders is expected to rise, creating a pressing need for innovative solutions that can help manage symptoms, restore lost functions, and improve the lives of affected individuals.

Global Brain Computer Interface Market Report Segmentation

This report forecasts revenue growth and provides at global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global brain computer interface market report based on product, application, end use, and region:

  • Brain-Computer Interface (BCI) Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Invasive Brain-Computer Interface (BCI) [Total Addressable Market (TAM)]
  • Non Invasive Brain-Computer Interface (BCI) [Serviceable Obtainable Market (SOM)]
  • Invasive Brain-Computer Interface (BCI) Application Outlook :(Revenue in USD Million; 2021 - 2033) [Total Addressable Market (TAM)]
  • MND/ALS
  • Stroke
  • Spinal Cord Injury
  • Multiple Sclerosis Patients
  • Cerebral Palsy
  • Amputation
  • Epilepsy
  • Depression
  • Parkinson's Disease
  • Non Invasive BCI Application Outlook (Revenue in USD Million; 2021 - 2033) [Serviceable Obtainable Market (SOM)]
  • Healthcare
    • Disabilities Restoration
    • Brain Function Repair
  • Smart Home Control
  • Communication and control
  • Entertainment & Gaming
  • Non Invasive BCI End Use Outlook (Revenue in USD Million, 2021 - 2033) [Serviceable Obtainable Market (SOM)]
  • Medical
  • Education & Research
  • Others (Consumer & Wellness, etc.)
  • Non Invasive BCI Regional Outlook (Revenue, USD Million, 2021 - 2033) [Serviceable Obtainable Market (SOM)]
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Application
    • 1.1.2. End Use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Brain Computer Interface Market Variables, Trends & Scope

  • 3.1. Market Dynamics
    • 3.1.1. Market driver analysis
    • 3.1.2. Market restraint analysis
    • 3.1.3. Market Opportunities
  • 3.2. Brain Computer Interface Market Analysis Tools
    • 3.2.1. Industry Analysis - Porter's
      • 3.2.1.1. Supplier power
      • 3.2.1.2. Buyer power
      • 3.2.1.3. Substitution threat
      • 3.2.1.4. Threat of new entrant
      • 3.2.1.5. Competitive rivalry
    • 3.2.2. PESTEL Analysis
      • 3.2.2.1. Political landscape
      • 3.2.2.2. Economic landscape
      • 3.2.2.3. Social landscape
      • 3.2.2.4. Technological landscape
      • 3.2.2.5. Environmental landscape
      • 3.2.2.6. Legal landscape
    • 3.2.3. Clinical Trial Pipelines in the BCI Technologies
    • 3.2.4. Case Studies

Chapter 4. Invasive Brain-Computer Interface (BCI) Total Addressable Market (TAM) Application Estimates & Trend Analysis

  • 4.1. Application Market Share, 2025 & 2033
  • 4.2. Segment Dashboard
  • 4.3. Global Brain Computer Interface Market by Application Outlook
  • 4.4. MND/ALS
    • 4.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.5. Stroke
    • 4.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.6. Spinal Cord Injury
    • 4.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.7. Multiple Sclerosis Patients
    • 4.7.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.8. Cerebral Palsy
    • 4.8.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.9. Amputation
    • 4.9.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.10. Epilepsy
    • 4.10.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.11. Depression
    • 4.11.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.12. Parkinson's Disease
    • 4.12.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 5. Non-Invasive Brain Computer Interface Market: Application Estimates & Trend Analysis

  • 5.1. Indication Market Share, 2025 & 2033
  • 5.2. Segment Dashboard
  • 5.3. Global Brain Computer Interface Market by Indication Outlook
  • 5.4. Healthcare
    • 5.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 5.4.2. Disabilities Restoration
    • 5.4.3. Market estimates and forecast 2021 to 2033 (USD Million)
    • 5.4.4. Brain Function Repair
    • 5.4.5. Market estimates and forecast 2021 to 2033 (USD Million)
  • 5.5. Smart Home Control
    • 5.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 5.6. Communication and control
    • 5.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 5.7. Entertainment & Gaming
    • 5.7.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. Non-Invasive Brain Computer Interface Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Market Share, 2025 & 2033
  • 6.2. Segment Dashboard
  • 6.3. Global Brain Computer Interface Market by End Use Outlook
  • 6.4. Medical
    • 6.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 6.5. Education & Research
    • 6.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 7. Non-Invasive Brain Computer Interface Market: Regional Estimates & Trend Analysis, By Type

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/ reimbursement structure
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/ reimbursement structure
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/ reimbursement structure
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/ reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/ reimbursement structure
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/ reimbursement structure
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/ reimbursement structure
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/ reimbursement structure
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Key company market share/position analysis, 2025
  • 8.4. Company Profiles
    • 8.4.1. Medtronic
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Technology Type benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. G.Tec medical engineering GmbH
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Technology Type benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Natus Medical Incorporated
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Technology Type benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Compumedics Neuroscan
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Technology Type benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Brain Products GmbH
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Technology Type benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Integra LifeSciences Corporation
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Technology Type benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Advanced Brain Monitoring, Inc.
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Technology Type benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. EMOTIV
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Technology Type benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. NeuroSky
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Technology Type benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. ANT Neuro
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Technology Type benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. NIRx Medical Technologies, LLC
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Technology Type benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. Ripple Neuro.
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Technology Type benchmarking
      • 8.4.12.4. Strategic initiatives
    • 8.4.13. Neuroelectrics
      • 8.4.13.1. Company overview
      • 8.4.13.2. Financial performance
      • 8.4.13.3. Technology Type benchmarking
      • 8.4.13.4. Strategic initiatives
    • 8.4.14. OpenBCI
      • 8.4.14.1. Company overview
      • 8.4.14.2. Financial performance
      • 8.4.14.3. Technology Type benchmarking
      • 8.4.14.4. Strategic initiatives
    • 8.4.15. COGNIONICS, INC. (CGX)
      • 8.4.15.1. Company overview
      • 8.4.15.2. Financial performance
      • 8.4.15.3. Technology Type benchmarking
      • 8.4.15.4. Strategic initiatives
    • 8.4.16. Blackrock Neurotech
      • 8.4.16.1. Company overview
      • 8.4.16.2. Financial performance
      • 8.4.16.3. Technology Type benchmarking
      • 8.4.16.4. Strategic initiatives
    • 8.4.17. Synchron
      • 8.4.17.1. Company overview
      • 8.4.17.2. Financial performance
      • 8.4.17.3. Technology Type benchmarking
      • 8.4.17.4. Strategic initiatives
    • 8.4.18. Neurable
      • 8.4.18.1. Company overview
      • 8.4.18.2. Financial performance
      • 8.4.18.3. Technology Type benchmarking
      • 8.4.18.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America brain computer interface market, by region, 2021 - 2033 (USD Million)
  • Table 4 North America brain computer interface market, by product, 2021 - 2033 (USD Million)
  • Table 5 North America brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 6 North America brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 7 U.S. brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 8 U.S. brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 9 Canada brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 10 Canada brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 11 Mexico brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 12 Mexico brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 13 Europe brain computer interface market, by region, 2021 - 2033 (USD Million)
  • Table 14 Europe brain computer interface market, by product, 2021 - 2033 (USD Million)
  • Table 15 Europe brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 16 Europe brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 17 Germany brain computer interface market, by product, 2021 - 2033 (USD Million)
  • Table 18 Germany brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 19 Germany brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 20 UK brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 21 UK brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 22 France brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 23 France brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 24 Italy brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 25 Italy brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 26 Spain brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 27 Spain brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 28 Denmark brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 29 Denmark brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 30 Sweden brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 31 Sweden brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 32 Norway brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 33 Norway brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 34 Asia Pacific brain computer interface market, by region, (USD Million) 2021 -
  • Table 35 Asia Pacific brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 36 Asia Pacific brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 37 China brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 38 China brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 39 Japan brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 40 Japan brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 41 India brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 42 India brain computer interface market, by end use, (USD Million) 2021 - 203
  • Table 43 South Korea brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 44 South Korea brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 45 Australia brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 46 Australia brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 47 Thailand brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 48 Thailand brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 49 Latin America brain computer interface market, by region, 2021 - 2033 (USD Million)
  • Table 50 Latin America brain computer interface market, by product, 2021 - 2033 (USD Million)
  • Table 51 Latin America brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 52 Latin America brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 53 Brazil brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 54 Brazil brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 55 Argentina brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 56 Argentina brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 57 MEA brain computer interface market, by region, 2021 - 2033 (USD Million)
  • Table 58 MEA brain computer interface market, by product, 2021 - 2033 (USD Million)
  • Table 59 MEA brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 60 MEA brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 61 South Africa brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 62 South Africa brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 63 Saudi Arabia brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 64 Saudi Arabia brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 65 UAE brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 66 UAE brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 67 Kuwait brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 68 Kuwait brain computer interface market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Brain computer devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 10 Non-invasive BCI segment snapshot
  • Fig. 12 Invasive BCI segment snapshot
  • Fig. 14 Brain computer interface market dynamics
  • Fig. 15 Emerging trends & technologies
  • Fig. 16 Brain computer interface market: PESTLE analysis
  • Fig. 17 Brain computer interface market: Porter's five forces analysis
  • Fig. 18 Non-Invasive Brain computer interface Serviceable Obtainable Market (SOM), Application outlook key takeaways (USD Million)
  • Fig. 19 Non-Invasive Brain computer interface Serviceable Obtainable Market (SOM): Application movement analysis, 2025 & 2033
  • Fig. 20 Healthcare Serviceable Obtainable Market (SOM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Disabilities restoration Serviceable Obtainable Market (SOM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Brain function repair Serviceable Obtainable Market (SOM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Smart home control Serviceable Obtainable Market (SOM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Communication and control Serviceable Obtainable Market (SOM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Entertainment & Gaming Serviceable Obtainable Market (SOM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Non-Invasive Brain computer interface Serviceable Obtainable Market (SOM), End Use outlook key takeaways (USD million)
  • Fig. 27 Non-Invasive Brain computer interface Serviceable Obtainable Market (SOM): End use movement analysis, 2025 & 2033 (USD Million)
  • Fig. 28 Medical market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Education and research Serviceable Obtainable Market (SOM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Others Serviceable Obtainable Market (SOM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Invasive brain computer interface Total Addressable Market (TAM), application outlook key takeaways (USD Billion)
  • Fig. 32 Invasive brain computer interface Total addressable market (TAM): Application movement analysis, 2025 & 2033
  • Fig. 33 MND/ALS Total Addressable Market (TAM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Stroke Total Addressable Market (TAM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Spinal cord injury Total Addressable Market (TAM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Multiple sclerosis Total Addressable Market (TAM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Cerebral palsy Total Addressable Market (TAM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Amputation Total Addressable Market (TAM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Epilepsy Total Addressable Market (TAM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Depression Total Addressable Market (TAM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Non-invasive brain computer interface serviceable obtainable market (SOM), by region
  • Fig. 42 Non-invasive brain computer interface serviceable obtainable market (SOM): Regional marketplace key takeaways (Part 1)
  • Fig. 43 Non-invasive brain computer interface serviceable obtainable market (SOM): Regional marketplace key takeaways (Part 2)
  • Fig. 44 Invasive brain computer interface Total Addressable Market (TAM), by region
  • Fig. 45 North America Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 46 North America Invasive Brain Computer Interface Total Addressable Market (TAM), 2021 - 2033 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 U.S. Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Canada Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Mexico Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 53 Europe Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 54 Europe Invasive Brain Computer Interface Total Addressable Market (TAM), 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 UK: Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Germany Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 France Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Italy Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Spain Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Norway Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Sweden Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Denmark Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 71 Asia Pacific Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 72 Asia Pacific Invasive Brain Computer Interface Total Addressable Market (TAM), 2021 - 2033 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Japan Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 China Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 India Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Australia Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 South Korea Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Thailand Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 85 Latin America Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 86 Latin America Invasive Brain Computer Interface Total Addressable Market (TAM), 2021 - 2033 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Brazil Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Argentina Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 91 MEA Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 92 MEA Invasive Brain Computer Interface Total Addressable Market (TAM), 2021 - 2033 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 South Africa Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Saudi Arabia Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 UAE Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 Kuwait Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 101 Key company categorization
  • Fig. 102 Key company categorization
  • Fig. 103 Y-o-Y funding trends in brain computer interface industry in Millions
  • Fig. 104 Y-o-Y funding rounds in brain computer interface industry
  • Fig. 105 Top Funding Rounds in last 2 years Part I
  • Fig. 106 Top Funding Rounds in last 2 years Part II
  • Fig. 107 Funding by geography in brain computer interface industry in Millions
  • Fig. 108 Y-o-Y stage-wise funding trends in brain computer interface industry in Millions
  • Fig. 109 Y-o-Y stage-wise funding trends in brain computer interface industry (Stage-wise number of rounds)
  • Fig. 110 Y-o-Y number of active investors in brain computer interface industry
  • Fig. 111 Company market position analysis
  • Fig. 112 Strategy mapping